By October, 2015, the Zika virus epidemic had grown substantially in Brazil with 14 states reporting autochtho nous Zika virus transmission. Concurrently, con cerns were raised regarding the discovery of a substantial increase in the number of microcephaly cases, particularly in the state of Pernambuco. The following month, a national public health emergency was declared in Brazil in response to growing concerns about the potential association between Zika virus and newborn microcephaly, with 1248 reported cases-20 times greater than the expected number.
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Following this announce ment, additional progress was made in establishing more defi nitive associations between Zika virus and congenital anomalies, including microcephaly. 2, 3 Studies in mouse models have addressed the causal relation between Zika virus infection in pregnancy and pathological changes in fetuses. 4, 5 Although a growing body of evidence suggests that Zika virus causes brain anomalies and microcephaly, describing what has been identifi ed as congenital Zika virus infec tion syndrome, there is a paucity of published prospective epidemiological studies. 3 A study by Thalia Araújo and colleagues 6 in The Lancet Infectious Diseases might be a missing piece to the puzzle, providing necessary epidemiological data to further advance our understanding of the association.
The investigators report preliminary fi ndings from the fi rst case-control study to examine the association between microcephaly and Zika virus infection, done prospectively in the metropolitan region of Recife in Pernambuco state, the hotspot of the microcephaly epidemic in Brazil. Their results highlight the striking magnitude of the association between microcephaly and laboratory-confi rmed Zika virus infection: the risk is 50 times higher in all microcephaly cases and more than 100 times higher in cases with brain abnormalities detected by imaging.
However, as acknowledged by Araújo and colleagues, microcephaly remains a poorly defi ned disorder, and a uniform diagnostic approach is urgently needed. There is much debate in Brazil and worldwide about ascertainment of microcephaly, and the issue of disproportionate and proportionate microcephaly needs further clarifi cation. Infants might be diagnosed with microcephaly when in fact they are globally small-ie, small for gestational age, without true isolated microcephaly. 7 This issue deserves attention, especially because in-utero growth restriction leading to the birth of small-for-gestational age infants is also a feature of congenital Zika virus syndrome. 2 Although disproportionate microcephaly has been the most publicised feature of congenital Zika virus infection, proportionate microcephaly is also identifi ed in the setting of in-utero growth restriction caused by maternal Zika virus infection during pregnancy, not unlike other congenital infections such as cytomega lovirus. The distinction, however, is important because there might be distinct prognostic implications. Although microcephaly has been associated with poor outcome in children with congenital cytomegalovirus disease, other researchers have not found such an association. A possible source of discrepancy is failure to adjust the head size to the weight of the infant when defi ning microcephaly. 8 Therefore, proportionality or lack thereof is becoming a very important parameter in ascertainment of microcephaly in Brazil. Likewise, categorising patients according to the presence of microcephaly and other CNS abnormalities as detected by brain imaging can enable the stratifi cation of patients into varying levels of disability risk.
As our knowledge of the clinical repercussions of congenital Zika virus infection advances, it becomes apparent that microcephaly is only one possible adverse outcome among a range of disorders that might be part of congenital Zika virus syndrome. A populationlevel increase in CNS anomalies was observed in French Polynesia and in Brazil. More data are needed to refi ne gestational age-specifi c risk estimates for microcephaly and other adverse outcomes related to Zika virus infection. 9 Therefore, even though the modifi ed Fenton curve 10 or the Intergrowth score 11 provide useful prognostic information, a full clinical assessment of the infant with clinical follow-up should provide more accurate information over time.
As defi nitions shift and more information is gathered about the pathogenesis and clinical manifestations of Zika virus congenital disease, it is important that surveillance eff orts monitoring the current epidemic continue to critically evaluate their data. Newly identifi ed clinical and phenotypic criteria should be further analysed, also taking into account fi ndings from imaging studies. This approach will help establish a more defi nitive gold standard case defi nition and improve our understanding of the clinical manifestations of congenital Zika virus infection.
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